Millipore Sigma Vibrant Logo

476485 PKA Inhibitor 14-22 Amide, Cell-Permeable, Myristoylated - Calbiochem

PKA Inhibitor 14-22 Amide is myristoylated at the N-terminus that enhances its cell-permeability. The non-myristoylated version is shown to be a specific inhibitor of PKA (Ki = 36 nM).

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: PKI 14-22 Amide, Cell-Permeable, Myr-GRTGRRNAI-NH₂, Myristoylated Protein Kinase A Inhibitor Amide 14-22, Cell-Permeable, Protein Kinase A Inhibitor 14-22 Amide, PKA Inhibitor XIII

Primary Target: cAMP-dependent protein kinase
View Products on Sigmaaldrich.com
476485
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

Empirical Formula
C₅₃H₁₀₀N₂₀O₁₂

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
476485-500UG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 500 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewHeat-stable protein kinase inhibitor (PKI) peptide sequence (14 - 22) that has been myristoylated at the N-terminus, enhancing its cell-permeability. The non-myristoylated version of this peptide is a highly specific inhibitor (Ki = 36 nM) of cAMP-dependent protein kinase.
      Catalogue Number476485
      Brand Family Calbiochem®
      SynonymsPKI 14-22 Amide, Cell-Permeable, Myr-GRTGRRNAI-NH₂, Myristoylated Protein Kinase A Inhibitor Amide 14-22, Cell-Permeable, Protein Kinase A Inhibitor 14-22 Amide, PKA Inhibitor XIII
      References
      ReferencesPaman, K., et al. 1998. J. Lipid Res. 39, 1091.
      Rimon, G., and Rubin M. 1998. Biochim. Biophys. Acta 1380, 289.
      Harris, T.E., et al. 1997. Biochem. Biophys. Res. Commun. 232, 648.
      Muniz, M., et al. 1997. Proc. Natl. Acad. Sci. USA 94, 14461.
      Zoukhri, D., et al. 1997. Am. J. Physiol. 272, C263.
      Eichholtz, T., et al. 1993. J. Biol. Chem. 268, 1982.
      Ward, N.E. and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      Walsh, D.A. and Glass, D.B. 1991. Methods Enzymol. 201, 304.
      Glass, D.B., et al. 1989. J. Biol. Chem. 264, 8802.
      Product Information
      ATP CompetitiveN
      FormLyophilized
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₅₃H₁₀₀N₂₀O₁₂
      Chemical formulaC₅₃H₁₀₀N₂₀O₁₂
      Hygroscopic Hygroscopic
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetcAMP-dependent protein kinase
      Primary Target K<sub>i</sub>36 nMf or cAMP-dependent protein kinase
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Peptide SequenceMyr-N-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH₂
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      476485-500UG 04055977183832

      Documentation

      PKA Inhibitor 14-22 Amide, Cell-Permeable, Myristoylated - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      PKA Inhibitor 14-22 Amide, Cell-Permeable, Myristoylated - Calbiochem Analysenzertifikate

      TitelChargennummer
      476485

      Literatur

      Übersicht
      Paman, K., et al. 1998. J. Lipid Res. 39, 1091.
      Rimon, G., and Rubin M. 1998. Biochim. Biophys. Acta 1380, 289.
      Harris, T.E., et al. 1997. Biochem. Biophys. Res. Commun. 232, 648.
      Muniz, M., et al. 1997. Proc. Natl. Acad. Sci. USA 94, 14461.
      Zoukhri, D., et al. 1997. Am. J. Physiol. 272, C263.
      Eichholtz, T., et al. 1993. J. Biol. Chem. 268, 1982.
      Ward, N.E. and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      Walsh, D.A. and Glass, D.B. 1991. Methods Enzymol. 201, 304.
      Glass, D.B., et al. 1989. J. Biol. Chem. 264, 8802.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision11-August-2008 RFH
      SynonymsPKI 14-22 Amide, Cell-Permeable, Myr-GRTGRRNAI-NH₂, Myristoylated Protein Kinase A Inhibitor Amide 14-22, Cell-Permeable, Protein Kinase A Inhibitor 14-22 Amide, PKA Inhibitor XIII
      DescriptionHeat-stable protein kinase inhibitor (PKI) peptide sequence (14-22) that has been myristoylated at the N-terminus, enhancing its cell-permeability. The non-myristoylated version of this peptide is a highly specific inhibitor (Ki = 36 nM) of cAMP-dependent protein kinase (PKA).
      FormLyophilized
      FormulationSupplied as a trifluoroacetate salt.
      Chemical formulaC₅₃H₁₀₀N₂₀O₁₂
      Peptide SequenceMyr-N-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH₂
      Purity≥95% by HPLC
      SolubilityH₂O (1 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesPaman, K., et al. 1998. J. Lipid Res. 39, 1091.
      Rimon, G., and Rubin M. 1998. Biochim. Biophys. Acta 1380, 289.
      Harris, T.E., et al. 1997. Biochem. Biophys. Res. Commun. 232, 648.
      Muniz, M., et al. 1997. Proc. Natl. Acad. Sci. USA 94, 14461.
      Zoukhri, D., et al. 1997. Am. J. Physiol. 272, C263.
      Eichholtz, T., et al. 1993. J. Biol. Chem. 268, 1982.
      Ward, N.E. and O’Brian, C.A. 1993. Biochemistry 32, 11903.
      Walsh, D.A. and Glass, D.B. 1991. Methods Enzymol. 201, 304.
      Glass, D.B., et al. 1989. J. Biol. Chem. 264, 8802.